BRAMPTON, Ont. — Loblaw beat analyst forecasts for the quarter, the Financial Post reports, boosted by strong sales in its pharmacy business at Shoppers Drug Mart, which the retail group acquired this year. Same-store front sales grew 2.5% at Shoppers, while Loblaw saw overall 1.6% growth. Loblaw’s revenue rose 36% to $13.6 billion, a quarter of that coming from Shoppers Drug Mart. The merger saved Loblaw about $44 million in the quarter, but also cost it $46 million in restructuring and reorganization expenses. Net earnings fell to $142 million from $150 million. Adjusted basic net earnings was 90 cents per share, slightly ahead of the average forecast of 87 cents.
Shoppers deal buoys Loblaw results
Most Recent
Most Read
HBC debuts Zellers locations
Fri, March 24th, 2023
Peavey sponsors Winter Fair
Fri, March 24th, 2023
Retail sales edge up in January
Fri, March 24th, 2023
Saskatchewan Ace store changes hands
Thu, March 23rd, 2023
Ace Canada holds virtual event
Thu, March 23rd, 2023
From the archives: Walmart Canada marks 20 years
Thu, March 23rd, 2023
Ontario TIMBER MART member enters Quebec market
Wed, March 22nd, 2023
Home Hardware unveils BeautiTone Colour of the Year
Wed, March 22nd, 2023
Newest Wolseley outlet to open in Ajax, Ont.
Wed, March 22nd, 2023
U.S. home resales log first rise in 12 months
Wed, March 22nd, 2023